{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:40:10Z","timestamp":1793054410510,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.tmaid.2020.101812","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:34:38Z","timestamp":1594035278000},"page":"101812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Hydroxychloroquine safety: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"36","author":[{"given":"Khalid","family":"Eljaaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasim Huseein","family":"Alireza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffar A.","family":"Al-Tawfiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.tmaid.2020.101812_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00894-018-3755-z","article-title":"Study of the antimalarial activity of 4-aminoquinoline compounds against chloroquine-sensitive and chloroquine-resistant parasite strains","volume":"24","author":"Lawrenson","year":"2018","journal-title":"J Mol Model"},{"key":"10.1016\/j.tmaid.2020.101812_bib2","series-title":"PLAQUENIL\u00ae (hydroxychloroquine sulfate) [package insert]","year":"2018"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101812_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.semarthrit.2013.01.001","article-title":"Multifaceted effects of hydroxychloroquine in human disease","volume":"43","author":"Olsen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.tmaid.2020.101812_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","article-title":"New insights into mechanisms of therapeutic effects of antimalarial agents in SLE","volume":"8","author":"Wallace","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101812_bib5","doi-asserted-by":"crossref","first-page":"101749","DOI":"10.1016\/j.tmaid.2020.101749","article-title":"Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients","author":"Eljaaly","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101812_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tmaid.2020.101812_bib7","article-title":"Infectious diseases society of America guidelines on the treatment and mnagement of patients with COVID-19","author":"Bhimraj","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101812_bib8","doi-asserted-by":"crossref","DOI":"10.7326\/M20-1998","article-title":"Should clinicians use chloroquine or hydroxychloroquine alone or in combination with azithromycin for the prophylaxis or treatment of COVID-19? Living practice points from the American College of Physicians (Version 1)","author":"Qaseem","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2020.101812_bib9","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","article-title":"Chapter 8: assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.tmaid.2020.101812_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.23822\/EurAnnACI.1764-1489.11","article-title":"Hydroxychloroquine in the treatment of antihistamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study","volume":"49","author":"Boonpiyathad","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.tmaid.2020.101812_bib11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.7326\/0003-4819-119-11-199312010-00002","article-title":"Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial","volume":"119","author":"Clark","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2020.101812_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9343(99)80399-4","article-title":"A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study","volume":"98","author":"The HERA Study Group","year":"1995","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101812_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00124743-199702000-00002","article-title":"Hydroxychloroquine effects on lipoprotein profiles (the HELP trial): a double-blind, randomized, placebo-controlled, pilot study in patients with systemic lupus erythematosus","volume":"3","author":"Kavanaugh","year":"1997","journal-title":"J Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.tmaid.2020.101812_bib14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.23471","article-title":"Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Lee","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.tmaid.2020.101812_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discovery"},{"key":"10.1016\/j.tmaid.2020.101812_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","article-title":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial","volume":"11","author":"Paton","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101812_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(01)05623-9","article-title":"Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study","volume":"358","author":"Van Gool","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2020.101812_bib18","unstructured":"Yokogawa N, Eto H, Tanikawa A, et al. Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial."},{"issue":"17","key":"10.1016\/j.tmaid.2020.101812_bib19","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1056\/NEJMicm1304542","article-title":"Hydroxychloroquine retinal toxicity","volume":"380","author":"Proano","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101812_bib20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/pds.2208","article-title":"Pitfalls in meta-analyses on adverse events reported from clinical trials","volume":"20","author":"Huang","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.tmaid.2020.101812_bib21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.tmaid.2020.101812_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.tmaid.2020.101812_bib23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.tmaid.2020.101812_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/rheumatology\/kex388","article-title":"Hydroxychloroquine-induced dark butterfly rash in a rheumatoid arthritis patient","volume":"57","author":"Pelechas","year":"2018","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.tmaid.2020.101812_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tmaid.2020.101812_bib26","first-page":"12857","article-title":"Plaquenil-induced erythroderma","author":"Slagel","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2020.101812_bib27","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMcpc1011319","article-title":"Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure","volume":"364","author":"Newton-Cheh","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2020.101812_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"Chen","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101812_bib29","first-page":"77","article-title":"Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review","volume":"2","author":"Joyce","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.tmaid.2020.101812_bib30","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.toxrep.2019.10.006","article-title":"Diagnostic pitfalls and laboratory test interference after hydroxychloroquine intoxication: a case report","volume":"6","author":"Radke","year":"2019","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.tmaid.2020.101812_bib31","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.200528","article-title":"Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection","author":"Juurlink","year":"2020","journal-title":"CMAJ"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:05:40Z","timestamp":1761487540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893920303082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"alternative-id":["S1477893920303082"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101812","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine safety: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101812"}}